Hua Linghu - Concepedia

Author

Hua Linghu

Chongqing Medical University ORCID

Also Known As

H Linghu, Hua Linghu, Linghu H, Linghu,Hua

Publications

598

Citations

H-Index

Concepts

All Affiliations

Chongqing Medical University The Affiliated Yongchuan Hospital of Chongqing Medical University Hokkaido University

About

Hua Linghu is an author at Chongqing Medical University specializing in medicine, ovarian cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	344
2	Cell Biology	6	6	283
3	Obstetrics	3	3	94
4	Pathology	3	3	147
5	Health Sciences	1	1	34

Hua Linghu

Publications

521

Citations

H-Index

Page 1

	Year	Citations
The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis Ya‐ling Che, Shujuan Luo, Gang Li, Cancer Letters MedicinePathologyTumor SuppressorCancer BiologyCell Biology	2015	68
Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS Hua Linghu, Masumi Tsuda, Yoshinori Makino, Oncogene Adaptor Protein CrkReceptor Tyrosine KinaseMalignant FeaturePathologyTumor Suppressor	2006	57
Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of β-catenin Lin Zhou, Mu Luo, Lijuan Cheng, Pathology - Research and Practice Nuclear LocationOncologyGlutamine-fructose-6-phosphate Transaminase 2Serous Ovarian CancerMedicine	2019	44
Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4 Lei Wang, Kouichi Tabu, Taichi Kimura, Biochemical and Biophysical Research Communications Neuro-oncologySignal TransductionSignaling PathwayGliomaAdaptor Protein Crk	2007	42
Elmo1 Helps Dock180 to Regulate Rac1 Activity and Cell Migration of Ovarian Cancer Jin Wang, Jie-Min Dai, Ya‐ling Che, International Journal of Gynecological Cancer	2014	42
Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB2/IIA2 cervical cancer Rui Li, Shentao Lu, Jing-ge Si, Gynecologic Oncology Surgical OncologyCervical CancerMedicinePrognostic ValueSurgery	2012	39
The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3 Hui Wang, Hua Linghu, Jin Wang, Tumor Biology	2009	38
ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway Mu Luo, Lin Zhou, Shijie Zhan, Biochemical and Biophysical Research Communications Aggressive PotentialEndocrine-related CancerMedicineGynecologyTumor Suppressor	2019	38
DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy Ruonan Li, Bin Liu, Xuemei Li, Scientific Reports	2017	36
Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis Shijie Zhan, Bin Liu, Hua Linghu Oncology Reports GynecologyCancer BiologyTumor BiologyOvarian CancerDrug Resistance	2018	34

Page 1